Literature DB >> 9070648

Actin cleavage by CPP-32/apopain during the development of apoptosis.

T Mashima1, M Naito, K Noguchi, D K Miller, D W Nicholson, T Tsuruo.   

Abstract

Interleukin-1beta-converting enzyme (ICE)/ced-3 family proteases play key roles in apoptosis. However, cellular substrates for ICE family proteases involved in apoptosis are not well understood. We previously showed that actin is cleaved in vitro by an ICE family protease, distinct from ICE itself, which is activated during VP-16-induced apoptosis. In this report, we demonstrate that the actin-cleaving ICE-family protease in the apoptotic cell extract is the activated CPP-32/apopain. CPP-32 effectively cleaves actin protein to 15 kDa and 31 kDa fragments. Studies with an antibody raised against Gly-Gln-Val-Ile-Thr peptide, the N-terminal sequence of the cleaved 15 kDa actin fragment, showed that actin is also cleaved in vivo during the development of apoptosis. Moreover, Benzyloxycarbonyl-Glu-Val-Asp-CH2OC(O)-2,6,-dichlorobenzene (Z-EVD-CH2-DCB), a selective inhibitor of CPP-32(-like) protease, efficiently inhibited the cleavage of actin and the apoptosis of VP-16-treated U937 cells. Our present results indicate that actin is the substrate of CPP-32/apopain(-like) protease both in vitro and in vivo and suggest the role of actin in the control of cell growth and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070648     DOI: 10.1038/sj.onc.1200919

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Redistribution of cytochrome c precedes the caspase-dependent formation of ultracondensed mitochondria, with a reduced inner membrane potential, in apoptotic monocytes.

Authors:  D Dinsdale; J Zhuang; G M Cohen
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.

Authors:  A A van de Loosdrecht; E Vellenga
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

3.  Morphological changes in the nucleus and actin cytoskeleton in the process of Fas-induced apoptosis in Jurkat T cells.

Authors:  W Maruyama; S Irie; T A Sato
Journal:  Histochem J       Date:  2000-08

Review 4.  Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?

Authors:  Charles P Gilman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.

Authors:  Tiancheng Liu; Lisa Y Wu; Clifford E Berkman
Journal:  Cancer Lett       Date:  2010-05-08       Impact factor: 8.679

6.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.

Authors:  Jie Du; Xiaonan Wang; Christiane Miereles; James L Bailey; Richard Debigare; Bin Zheng; S Russ Price; William E Mitch
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 7.  Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways.

Authors:  Helen M Beere
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

8.  Actin cleavage in various tumor cells is not a critical requirement for executing apoptosis.

Authors:  R L Rice; D G Tang; J D Taylor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

10.  Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.

Authors:  Shang-Yi Tsai; Teruo Hayashi; Brandon K Harvey; Yun Wang; Wells W Wu; Rong-Fong Shen; Yongqing Zhang; Kevin G Becker; Barry J Hoffer; Tsung-Ping Su
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.